Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 88389th Legislature (2025)

Relating to patient access to prescription drugs for off-label use for COVID-19 treatment.

Read the full bill

Progress

  1. Introduced
  2. In committee
  3. Passed Senate
  4. Passed legislature Not yet
  5. Sent to governor Not yet
  6. Became law Not yet

What this bill would cost

Fiscal notes are prepared by the state’s budget staff and reflect the bill as written at the time.

Committee hearings

  1. April 1, 2025

    Senate Health & Human Services Committee · Left pending in committee

    Testified: 3 for, 0 against, 0 on (neutral) · Registered without testifying: 1 for, 1 against, 1 on

    Organizations for
    Make Texans Healthy Again
    Organizations on (neutral)
    Texas Medical Board

    Official witness list

  2. April 2, 2025

    Senate Health & Human Services Committee · Reported favorably w/o amendments

Source: Texas Legislature (Texas Legislative Council). Witness lists show how many people took each position and the organizations they represented; people speaking for themselves are counted but not named here.

Committee votes

  • House Public Health · In committee
  • Senate Health & Human Services · Out of committee 8 aye, 1 nay

Bill analyses: Introduced

Legislative history

  1. House

    Referred to Public Health

  2. House

    Read first time

  3. House

    Received from the Senate

  4. Senate

    Reported engrossed

  5. Senate

    Passed

  6. Senate

    Read 3rd time

  7. Senate

    Read 2nd time & passed to engrossment

  8. Senate

    Record vote

  9. Senate

    Rules suspended-Regular order of business

  10. Senate

    Co-author authorized

  11. Senate

    Placed on intent calendar

  12. Senate

    Committee report printed and distributed

  13. Senate

    Reported favorably w/o amendments

  14. Senate

    Vote taken in committee

  15. Senate

    Considered in public hearing

  16. Senate

    Left pending in committee

  17. Senate

    Testimony taken in committee

  18. Senate

    Considered in public hearing

  19. Senate

    Scheduled for public hearing on . . .

  20. Senate

    Co-author authorized

  21. Senate

    Referred to Health & Human Services

  22. Senate

    Read first time

  23. Senate

    Filed

  24. Senate

    Received by the Secretary of the Senate